caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528355872

Ketan BakriwalaO.D.

PRACTICECASTILLEJOS EYE INSTITUTE MEDICAL GROUPSee all providers at this practice →
OptometryChula Vista, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
220
Unique beneficiaries
—
Total services
225
Distinct HCPCS
5
Medicare payment
$19K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,493 Optometry providers in CA — above median (cohort median 147).
REFERRAL NETWORK

Where Ketan Bakriwala's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Gordon Montgomery
Specialist · Chula Vista, CA
68183
PRIME HEALTHCARE PARADISE VALLEY LLC59140
Unilab Corporation
Clinical Laboratory · West Hills, CA
4193
Ira Braverman
Internal Medicine · National City, CA
2579
John Holden
Diagnostic Radiology · Pasadena, CA
2053
Irineo Tiangco
Internal Medicine · National City, CA
1856
Dottie Ann Sazon
Pulmonary Disease · National City, CA
1566
Tagumpay Sacamay
Nephrology · National City, CA
1450
Maria Lourdes Mara
Internal Medicine · San Diego, CA
1357
ROBINSON, JEROME1330
SHARP CHULA VISTA MEDICAL CENTER1222
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
103
Beneficiaries
—
Total drug cost
$24K
Distinct drugs
4
Brand share
49.5%
Top prescribed drugs
Latanoprost52 claims
Lifitegrast26 claims
Erythromycin Base14 claims
Neomycin/Polymyxin B/Dexametha11 claims
QUALITY · MIPS · 2024
Final MIPS score
88.7
Quality
81.0
Cost
82.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.58%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$365
Payment records
8
By payment type
Food and Beverage$365